Retatrutide Research Momentum Retatrutide remained one of the week’s strongest peptide-research topics, driven by comparison questions around tirzepatide, semaglutide, and cagrilintide plus renewed attention on GLP-1/GIP/glucagon receptor pathways. The research conversation is moving beyond single-agent GLP-1 models toward multi-receptor signaling…
Subject: Retatrutide Research Update: GLP-1 Trends Retatrutide continues to stand out as one of the most closely watched metabolic research compounds in the current peptide landscape. In recent trend monitoring, retatrutide showed strong year-over-year search growth and continued week-over-week momentum,…
Subject: Retatrutide Research Update: GLP-1 Trends Retatrutide continues to stand out as one of the most closely watched metabolic research compounds in the current peptide landscape. In recent trend monitoring, retatrutide showed strong year-over-year search growth and continued week-over-week momentum,…
On April 15, 2026, the FDA made one of the most significant regulatory moves in the peptide space in years: they removed 12 peptides — including BPC-157, TB-500, and Semax — from the Category 2 restricted substances list. If you’ve…
A comprehensive research-based FAQ on BPC-157 side effects, covering what preclinical data shows, common questions from the research community, and important safety context.
BPC-157 side effects — a research-based FAQ covering safety data, common reactions, injection site issues, cancer risk, and what Reddit gets wrong.
BPC-157 oral vs injectable — which route shows better bioavailability? Learn the research differences, stability, absorption, and GI-specific effects.
New to peptides? Start here. A comprehensive guide covering what peptides are, how they work, what the research says, and how to evaluate suppliers. Written for Canadians.
Complete guide for Canadian researchers on CJC-1295 peptides, covering DAC vs no-DAC differences, research applications, dosing protocols, storage guidelines, and Canadian regulatory considerations.
What Is GHK-Cu? GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper peptide complex found in human blood, saliva, and urine. First isolated in 1973 by Dr. Loren Pickart, this tripeptide has become one of the most researched peptides for skin…